THE EFFECT OF COMBINATIONS OF GROWTH FACTORS AND HYALURONIC ACID ON THE PROLIFERATION AND CHONDROGENIC DIFFERENTIATION OF HUMAN SYNOVIUM DERIVED MESENCHYMAL STEM CELLS
Main Article Content
Authors
G. Zhubanova
National Center for Biotechnology, Korgalzhyn highway13/5, Nur-Sultan, Kazakhstan
A. Mukhambetova
National Center for Biotechnology, Korgalzhyn highway13/5, Nur-Sultan, Kazakhstan
M. Karzhauov
National Center for Biotechnology, Korgalzhyn highway13/5, Nur-Sultan, Kazakhstan
A. Issabekova
National Center for Biotechnology, Korgalzhyn highway13/5, Nur-Sultan, Kazakhstan
E. Raimagambetov
National Scientific Center for Traumatology and Ortopedics, Abylai Khan Avenue 15a, Nur-Sultan, Kazakhstan
V. Ogay
National Center for Biotechnology, Korgalzhyn highway13/5, Nur-Sultan, Kazakhstan
Abstract
Growth factors and hyaluronic acid (HA) have been shown to stimulate functional activity of mesenchymal stem cells (MSCs) and thus may influence damaged tissue healing, including cartilage. In this study we investigated the effects of individual and combinatorial application of HA, platelet derived growth factor–BB (PDGF-BB), transforming growth factor β1 (TGF-β1), bone morphogenetic protein-4 (BMP-4) and fibroblast growth factor-2 (FGF-2) on the proliferation and chondrogenic differentiation of human synovium derived MSCs (SD MSCs). Isolated SD MSCs were expanded in α-MEM medium and characterized using immunocytochemistry, multilineage differentiation assay and CFU-assay. Proliferation activity of MSCs was examined with MTT-assay. Chondrogenic differentiation and glycosaminoglycan level in micro-pellet culture of MSCs were evaluated with histochemical and biochemical analysis.
Our results showed that the individual use of FGF-2 and PDGF-BB significantly increased the rate of MSC proliferation compared to the control. At the same time, TGF-β1 did not affect cell growth. Combinations of growth factors: TGF-β1+FGF-2, TGF-β1+PDGF-BB, and FGF-2+PDGF-BB were able to significantly increase the proliferative activity of MSCs. The greatest synergistic effect was found with combination of all three factors TGF-β1, FGF-2, and PDGF-BB. Histochemical and biochemical analysis revealed that combination of TGF-β1 and BMP-4 have a significant effect on chondrogenic differentiation and the synthesis of glycosaminoglycans in micro-pellet culture of MSCs. The addition of HA to growth factors has minor effect on the proliferation and does not affect the chondrogenic differentiation of MSCs.
This study demonstrated that combination of growth factors can promote proliferation and chondrogenic differentiation of SD MSCs and may be effective in enhancing cartilage healing.
Keywords
synovium derived mesenchymal stem cells, cell proliferation, chondrogenic differentiation, growth factors, hyaluronic acid
Article Details
References
Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem cells, 2004, vol. 22, pp. 487–500. doi: 10.1634/stemcells.22-4-487.
De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis& Rheumatism, 2001, vol. 44, pp. 1928–1942. doi: 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P.
Zuk PA, Zhu M, Mizino H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 2001, vol. 7, pp. 211–228. doi: 10.1089/107632701300062859.
S. Kokabu, J. W. Lowery, and E. Jimi. Cell fate and differentiation of bone marrow mesenchymal stem cells. Stem Cells International, 2016, 2016:3753581. doi: 10.1155/2016/3753581.
Danišovič L, Varga I, Polák S. Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue Cell, 2012, vol. 44(2), pp. 69-73. doi: 10.1016/j.tice.2011.11.005.
Rosier RN, O'Keefe RJ, Crabb ID, Puzas JE. Transforming growth factor beta: an autocrine regulator of chondrocytes. Connective Tissue Research, 1989, vol. 20, pp. 295–301. doi: 10.3109/03008208909023900.
Zhao L, Hantash BM. TGF-β1 regulates differentiation of bone marrow mesenchymal stem cells. Vitamins&Hormones, 2011, vol. 87, pp. 127-141. doi: 10.1016/B978-0-12-386015-6.00042-1.
Miljkovic ND, Cooper GM, Marra KG. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis and Cartilage, vol. 16, pp. 1121-1130. doi: 10.1016/j.joca.2008.03.003.
Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem, 2011, vol. 149, pp. 121-30. doi: 10.1093/jb/mvq121.
Rider DA, Dombrowski C, Sawyer AA, Ng GH, Leong D, Hutmacher DW, Nurcombe V, Cool SM. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells, 2008, vol. 26, pp. 1598-608. doi: 10.1634/stemcells.2007-0480.
Donovan J, Abraham D, Norman J. Platelet-derived growth factor signaling in mesenchymal cells. Frontiers in Bioscience-Landmark, 2013, vol. 18, pp. 106-119. doi: 10.2741/4090.
Heldin CH. Autocrine PDGF stimulation in malignancies. Upsala Journal of Medical Sciences, 2012, vol. 117, pp. 83–91. doi: 10.3109/03009734.2012.658119.
Vantler M, Karikkineth BC, Naito H et al. PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue. Journal of Molecular Cellular Cardiology, 2010, vol. 48, pp. 1316–1323. doi: 10.1016/j.yjmcc.2010.03.008.
Qiu P, Song W, Niu Z, Bai Y, Li W, Pan S, Peng S, Hua J. Platelet-derived growth factor promotes the proliferation of human umbilical cord-derived mesenchymal stem cells. Cell Biochemistry & Function, 2013, vol. 31, pp. 159-165. doi: 10.1002/cbf.2870.
Murakami T, Otsuki S, Okamoto Y, Nakagawa K, Wakama H, Okuno N, Neo M. Hyaluronic acid promotes proliferation and migration of human meniscus cells via a CD44-dependent mechanism. Connective Tissue Research, 2019, vol. 60, pp. 117-127. doi: 10.1080/03008207.2018.1465053.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 1983, vol. 65, pp. 55-63. doi: 10.1016/0022-1759(83)90303-4.
Kim Y-J, Sah, RLY, Doong,J-YH.,Grodzinsky, AJ. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Analytical Biochemistry, 1988, vol. 174, pp. 168-176. doi: 10.1016/0003-2697(88)90532-5.
Estes BT, Diekman, B.O., Gimble, J.M., Guilak, F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nature Protocols, 2010, vol. 5, pp. 1294-1311. doi: 10.1038/nprot.2010.81.
Brodkin KR, Garcı´a AJ, Levenston ME. Chondrocyte phenotypes on different extracellular matrix monolayers. Biomaterials, 2004, vol. 25, pp. 5929-5938. doi: 10.1016/j.biomaterials.2004.01.044.
Bekbolsynov D, Mukhambetova, , Ogay V, Raimagambetov, E. Mesenchymal stem cells in hyaluronic acid scaffold as a therapeutic tool for osteoarthritis – Preliminary report. Bulletin of KazNU. Biological series, 2012, vol. 56, № 4, pp. 355-358.
Makris EA, Gomoll AH, Malizos KN, Hu JC, Athanasiou KA. Repair and tissue engineering techniques for articular cartilage. Nat Rev Rheumatol, 2015, vol. 11, pp. 21-34. doi:v10.1038/nrrheum.2014.157.
Ahmed TA, Hincke MT. Strategies for articular cartilage lesion repair and functional restoration. Tissue Eng Part B Rev., 2010, vol. 16, pp. 305-29. doi: 10.1089/ten.TEB.2009.0590.
Serra R., Johnson M., Filvaroff E.H., LaBorde J., et al. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. Journal of Cell Biology, 1997, vol. 139, pp. 541–552. doi: 10.1083/jcb.139.2.541.
Dunker N., Schmitt K., Krieglstein K. TGF-beta is required for programmed cell death in interdigital webs of the developing mouse limb. Mechanisms of Development, 2002, vol. 113, pp. 111–120. doi: 10.1016/s0925-4773(02)00015-1.
Blaney E.N., Davidson, van der Kraan P.M., van den Berg W.B. TGF-beta and Osteoarthritis. Osteoarthritis and Cartilage, 2007, vol. 15, pp. 597–604. doi: 10.1016/j.joca.2007.02.005.
Ng F., Boucher S., Koh S., Sastry K.S. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood, 2008, vol. 112, pp. 295-307. doi: 10.1182/blood-2007-07-103697.
Miljkovic N.D., Cooper G.M., Marra K.G. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis and Cartilage, 2008, vol. 16, pp. 1121-1130. doi: 10.1016/j.joca.2008.03.003.
Article Sidebar
